| 產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| 201076-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[3,5-二(三氟甲基)苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C37H27F12O4P | |
| 201076-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-雙[3,5-二(三氟甲基)苯基]螺環(huán)二酚磷酸酯 (11aR)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C37H27F12O4P | |
| 201075-1G |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二苯基螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C33H31O4P | |
| 201075-100MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二苯基螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C33H31O4P | |
| 201075-25MG |
|
NA |
(S)-10,10,13,13-四甲基-3,7-二苯基螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C33H31O4P | |
| 201074-1G |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二苯基螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C33H31O4P | |
| 201074-100MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二苯基螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C33H31O4P | |
| 201074-25MG |
|
NA |
(R)-10,10,13,13-四甲基-3,7-二苯基螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-diphenyl-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C33H31O4P | |
| 201073-1G |
|
NA |
(S)-10,10,13,13-四甲基-螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C21H23O4P | |
| 201073-100MG |
|
NA |
(S)-10,10,13,13-四甲基-螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C21H23O4P | |
| 201073-25MG |
|
NA |
(S)-10,10,13,13-四甲基-螺環(huán)二酚磷酸酯 (11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C21H23O4P | |
| 201072-1G |
|
NA |
(R)-10,10,13,13-四甲基-螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
1G | 需詢價 | C21H23O4P | |
| 201072-100MG |
|
NA |
(R)-10,10,13,13-四甲基-螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價 | C21H23O4P | |
| 201072-25MG |
|
NA |
(R)-10,10,13,13-四甲基-螺環(huán)二酚磷酸酯 (11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 請咨詢 大賽璐 ≥98%,99%e.e. |
25MG | 需詢價 | C21H23O4P | |
| 201145-500MG |
|
NA |
3-叔丁基-4-(4',6'-二甲氧-3',5'-二苯基苯基)-2,3-二氫-1,3-苯并氧膦雜環(huán)] 3-(tert-Butyl)-4-(4',6'-dime thoxy-[1,1':3',1''-terphenyl]-5'-yl)-2,3-dihydrobenzo[d ][1,3]oxaphosphole 請咨詢 大賽璐 ≥95%,99%e.e. |
500MG | 需詢價 | C31H31O3P | |
| 201145-100MG |
|
NA |
3-叔丁基-4-(4',6'-二甲氧-3',5'-二苯基苯基)-2,3-二氫-1,3-苯并氧膦雜環(huán)] 3-(tert-Butyl)-4-(4',6'-dime thoxy-[1,1':3',1''-terphenyl]-5'-yl)-2,3-dihydrobenzo[d ][1,3]oxaphosphole 請咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價 | C31H31O3P | |
| 201144-500MG |
|
NA |
2-[(2S,3S)-4-(9-蒽基)-3-叔丁基-2,3-二氫-1,3-苯并氧膦雜環(huán)]吡啶 2-[(2S,3S)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-pyridine 請咨詢 大賽璐 ≥95%,99%e.e. |
500MG | 需詢價 | C30H26NOP | |
| 201144-100MG |
|
NA |
2-[(2S,3S)-4-(9-蒽基)-3-叔丁基-2,3-二氫-1,3-苯并氧膦雜環(huán)]吡啶 2-[(2S,3S)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-pyridine 請咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價 | C30H26NOP | |
| 201143-500MG |
|
1542796-14-4 |
2-[(2R,3R)-4-(9-蒽基)-3-叔丁基-2,3-二氫-1,3-苯并氧膦雜環(huán)]吡啶 2-[(2R,3R)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-pyridine 請咨詢 大賽璐 ≥95%,99%e.e. |
500MG | 需詢價 | C30H26NOP | |
| 201143-100MG |
|
1542796-14-4 |
2-[(2R,3R)-4-(9-蒽基)-3-叔丁基-2,3-二氫-1,3-苯并氧膦雜環(huán)]吡啶 2-[(2R,3R)-4-(9-Anthracenyl)-3-(1,1-dimethylethyl)-2,3-dihydro-1,3-benzoxaphosphol-2-yl]-pyridine 請咨詢 大賽璐 ≥95%,99%e.e. |
100MG | 需詢價 | C30H26NOP | |
小泰
|
010-60710855
|